2-氧化吲哚-6-甲酸甲酯 | 14192-26-8

• 物质功能分类: 医药中间体 - 杂环化合物 - 吲哚类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 2-氧化吲哚-6-甲酸甲酯
• 中文别名: 6-羧酸甲酯二氢吲哚-2-酮；2-氧代吲哚啉-6-甲酸甲酯；6-甲氧羰基-2-吲哚酮；6-甲酸甲酯吲哚-2-酮；2-氧代吲哚-6-羧酸甲酯
• 英文名称: methyl 2-oxoindoline-6-carboxylate
• 英文别名: methyl 2-oxindole-6-carboxylate；6-methoxycarbonyl-2-oxoindoline；methyl 2-oxo-2,3-dihydro-1H-indole-6-carboxylate；methyl oxindole-6-carboxylate；methyl 2-oxoindole-6-carboxylate；methyl 2-oxo-1,3-dihydroindole-6-carboxylate
• CAS: 14192-26-8
• 化学式: C₁₀H₉NO₃
• 分子量: 191.186
• InChiKey: YFTGUNWFFVDLNM-UHFFFAOYSA-N

物化性质

• 熔点：
  184-190°C
• 沸点：
  388.1±42.0 °C(Predicted)
• 密度：
  1.283±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2933790090
• 危险标志：
  GHS07
• 危险性描述：
  H302,H317
• 危险性防范说明：
  P280
• 储存条件：
  存储条件：室温、密封、干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl oxindole-6-carboxylate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl oxindole-6-carboxylate
CAS number: 14192-26-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H9NO3
Molecular weight: 191.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

2-氧化吲哚-6-甲酸甲酯是一种用于制备BIBF 1120的中间体。BIBF 1120作为一种三联血管激酶抑制剂，属于吲哚满酮类药物。

反应信息

• 作为反应物：
  描述：

  2-氧化吲哚-6-甲酸甲酯 在 甲醇 、 乙酸酐 作用下， 以 甲醇 、 水 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 13.5h， 生成 乙磺酸尼达尼布
  参考文献：
  名称：

  一种制备乙磺酸尼达尼布的方法

  摘要：

  本发明公开了一种制备乙磺酸尼达尼布的方法，该方法包括以2‑氧化吲哚‑6‑甲酸甲酯与醋酐经酰化反应，得到1‑乙酰基‑2‑氧代二氢吲哚‑6‑甲酸甲酯；再与原苯甲酸三甲酯缩合生成1‑乙酰基‑3‑(甲氧基苯基亚甲基)‑2‑氧代二氢吲哚‑6‑甲酸甲酯，最后与N‑(4‑氨基苯基)‑N，4‑二甲基‑1‑哌嗪乙酰胺反应；在不分离主产物的情况下加碱脱保护，生成尼达尼布，最后与乙磺酸成盐生成乙磺酸尼达尼布。本发明反应条件温和，工艺操作简便，收率高，无需精制便可得纯度高达100％的乙磺酸尼达尼布，适合工业化生产。

  公开号：

  CN111848486B
• 作为产物：
  描述：

  间硝基苯甲酸 在 硫酸 、 palladium on activated charcoal 、 potassium tert-butylate 、 氢气 、 溶剂黄146 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 2-氧化吲哚-6-甲酸甲酯
  参考文献：
  名称：

  用于改善药代动力学特性的氘代尼达尼布的设计、合成和生物学评价

  摘要：

  尼达尼布是一种新型三联血管激酶抑制剂，可同时抑制三种生长因子。在体外和体内制备和评估了某些代谢活性位点的尼达尼布氘代衍生物。特别是，与尼达尼布相比，氘代化合物 SKLB-C2202 具有显着改善的药代动力学特性。这些努力为进一步研究 SKLB-C2202 的成药性奠定了基础。

  DOI：

  10.1002/jlcr.3299

文献信息

• Multicyclic bis-amide MMP inhibitors
  申请人：Powers Timothy

  公开号：US20060173183A1

  公开（公告）日：2006-08-03

  The present invention relates generally to bis-amide group containing pharmaceutical agents, and in particular, to multicyclic bis-amide MMP-13 inhibitor compounds. More particularly, the present invention provides a new class of MMP-13 inhibiting compounds, containing a pyrimidinyl bis-amide group in combination with a heterocyclic moiety, that exhibit an increased potency and solubility in relation to currently known bis-amide group containing MMP-13 inhibitors.

  本发明总体涉及含有双酰胺基团的药物制剂，特别是多环双酰胺MMP-13抑制剂化合物。更具体地，本发明提供了一类新型的MMP-13抑制化合物，它们含有与杂环部分结合的嘧啶基双酰胺基团，与目前已知含双酰胺基团的MMP-13抑制剂相比，显示出增加的活性和溶解度。
• A Mild and Direct C(sp₃)–S Cross-Coupling of Oxindoles with Thiols: Synthesis of Unsymmetrical 3-Thiooxindoles
  作者：Hui Qin、Qi Li、Jian Xu、Jie Zhang、Wei Qu、Wenyuan Liu、Feng Feng、Haopeng Sun

  DOI：10.1021/acs.joc.9b02205

  日期：2019.11.1

  Herein, an operationally simple and mild strategy to construct sulfenation of oxindoles with a series of thiols in the absence of transition metals was developed. This methodology provides an efficient way to directly form a C-S bond at the C-3 position of oxindoles under mild reaction conditions with a cheap and common solvent and base in moderate to good yields.

  本文中，开发了一种在不存在过渡金属的情况下用一系列硫醇构造羟吲哚硫化的操作简单温和的策略。这种方法学提供了一种有效的方法，可以在温和的反应条件下，以廉价和常用的溶剂和碱在中等至良好的收率下，在羟吲哚的C-3位直接形成CS键。
• Facile synthesis of pyrroloindoles <i>via</i> a rhodium(<scp>ii</scp>)-catalyzed annulation of 3-benzylidene-indolin-2-ones and α-imino carbenes
  作者：Xueji Ma、Xuemei Xie、Li Liu、Ran Xia、Tongyu Li、Hangxiang Wang

  DOI：10.1039/c7cc08438b

  日期：——

  A novel carbenoid strategy to construct pyrrole-fused indole alkaloids.

  一种新颖的碳亚甲基策略用于构建咔唑并融合吲哚生物碱。
• [EN] ANTIBODY-ALK5 INHIBITOR CONJUGATES AND THEIR USES<br/>[FR] CONJUGUÉS D'ANTICORPS-INHIBITEUR ALK5 ET LEURS UTILISATIONS
  申请人：SYNTHIS LLC

  公开号：WO2020013803A1

  公开（公告）日：2020-01-16

  The present disclosure relates to antibody-drug conjugates comprising ALK5 inhibitors and their uses.

  本公开涉及包含ALK5抑制剂的抗体药物偶联物及其用途。
• ANTIBODY-ALK5 INHIBITOR CONJUGATES AND THEIR USES
  申请人：Synthis, LLC

  公开号：US20200147234A1

  公开（公告）日：2020-05-14

  The present disclosure relates to antibody-drug conjugates comprising ALK5 inhibitors and their uses.

  本公开涉及包含ALK5抑制剂的抗体药物偶联物及其用途。